Welcome to The CAPS Community!
This revolutionary service pools the resources of the Motley Fool Community to help you identify the best stocks at the best times to buy them -- and which stocks to avoid. Learn More or watch a quick intro video from David Gardner.
Be a smarter investor in just 3 steps...
-
Rate Stocks
Test your picks against the best investors. Rate a stock!
-
Research Stocks
Tap into community intelligence to find the best stocks. Find stock ideas!
Recent Stock Pitches
-
UnderperformVerizon Communications, Inc. (VZ)
Not a great investment option based on managements ill-fated decision to buy AOL and parts of Yahoo! just as it would face huge costs for a 5G upgrade. Too many concerns about how management is using shareholder capital.
-
Outperform
-
Outperform
-
OutperformPacific Ethanol Inc (PEIX)
Senior officer open market purchases since it fell below $10.00 and having traded much higher i recent years.
-
Underperform
-
OutperformCallaway Golf Company (ELY)
The new acquisition adds diversity and a new international exposure, while keeping the balance sheet in decent shape. They also have ownership in the Top Golf franchise which is growing fast.
-
OutperformChico's FAS, Inc. (CHS)
Having traded above $17.00 in recent years and an open market purchase by an insider much more recently than any insider open market sale.
-
OutperformCRISPR Therapeutics (CRSP)
Is there anything potentially more transformational that altering biology itself???
-
Outperform
-
Outperform
-
Outperform
-
Outperform
-
OutperformALLY FINANCIAL (ALLY)
Selling below its asset value and has growing earnings and somewhat of a Moat by having a large share of the automobile finance sector
-
Outperform
-
OutperformKimberly-Clark Corp (KMB)
Overvalued big cap. Many people believe big caps are safer investments than they actually are. When valuations are THIS high the stock is likely to fall far below triple digits sooner or later.
-
OutperformOcular Therapeutix, Inc. (OCUL)
price target raised by analysts at Cantor Fitzgerald from $22.00 to $24.00 on Monday. They now have an "overweight" rating on the stock. 312.4% upside from the current price of $5.82.
-
OutperformNew Age Beverages Corp (NBEV)
price target raised by analysts at Roth Capital from $7.00 to $10.00 on Tuesday. They now have a "buy" rating on the stock. 113.2% upside from the current price of $4.69.
-
OutperformMarinus Pharma (MRNS)
given a new $19.00 price target on by analysts at Cantor Fitzgerald on Tuesday. They now have a "buy" rating on the stock. 267.5% upside from the current price of $5.17.
-
Outperform
-
Outperform




